Key result
Longer daily standing is linked to ~92% higher peripheral edema risk in patients on CCBs.
Why the study?
Calcium channel blockers can cause peripheral edema leading to additional therapy and reduced adherence, but its incidence and risk factors among hypertensive patients in Ethiopia were uncharacterized.
What is the incidence and what are the risk factors for calcium channel blocker-related edema in hypertensive patients?
Cohort (n=292)
Yes
What is the incidence and what are the risk factors for calcium channel blocker-related edema in hypertensive patients?
Peripheral edema is a common adverse effect of calcium channel blockers, occurring in over one-third of patients, with higher doses and longer daily standing duration increasing the risk.
Answers are grounded in this paper and cite their sources.
Longer standing may heighten CCB edema risk in hypertension; hypothesis-generating and requires prospective validation before practice change.
Background Hypertension is a major risk factor for cardiovascular disease and remains the leading cause of mortality worldwide. Calcium channel blockers (CCBs) are commonly used to lower blood pressure because they are effective and affordable. However, CCBs can cause vasodilatory adverse effects, including peripheral edema, which may lead to additional therapy and affect adherence. This study assessed the incidence and risk factors of CCB-related edema among hypertensive patients in Ethiopia. Methods This retrospective multicenter cohort study involved interviews and reviews of medical records of adults (aged ≥18 years) with essential hypertension who were prescribed calcium channel blockers (CCBs) between July 15 and August 14, 2025. A total of 292 participants were selected using systematic random sampling. A structured questionnaire was used to collect sociodemographic and clinical data. Descriptive statistics summarized baseline characteristics. Time-to-event analysis with the log-rank test assessed the duration from CCB initiation to edema onset. Binary and multivariate logistic regression analyses identified factors associated with CCB-related edema, and a p -value <0.05 was considered statistically significant. Results Among 292 participants (mean age 58.2 years; 53.4% female), 20.9% had diabetes mellitus and 16.8% had dyslipidemia. Amlodipine was the most frequently prescribed CCB (94.8%). Peripheral edema developed in 38.7% of patients, with a mean onset time of 8.3 weeks. In multivariate analysis, only longer daily standing duration was significantly associated with edema (AOR = 1.92; 95% confidence interval: 1.03–3.58; p = 0.041). Time-to-event analysis showed a progressive increase in edema risk with continued CCB use. Patients receiving amlodipine 10 mg daily had a greater (42.5% vs. 33%) and earlier risk of edema than those on 5 mg amlodipine daily; log-rank p = 0.003). Conclusions Peripheral edema occurred in over one-third of hypertensive patients on CCBs, appearing on average after eight weeks. Longer daily standing and higher CCB doses increased risk and earlier onset. Clinicians should inform patients and avoid unnecessary interventions. Further research on upright posture and edema is warranted.
No takes yet. Share an insight, caveat, or question.
Tolla et al. (2025) conducted a cohort in Essential hypertension (n=292). Longer daily standing duration vs. Shorter daily standing duration was evaluated on Development of peripheral edema (AOR 1.92, 95% CI 1.03-3.58, p=0.041). Peripheral edema occurred in 38.7% of hypertensive patients on calcium channel blockers, with longer daily standing duration increasing the risk.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: